TMO vs SYK
By Alex · Tickerpine
Thermo Fisher Scientific Inc. vs Stryker Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | TMO | SYK |
|---|---|---|
| Price | $700.22 | $309.64 |
| Market cap | $259.44B | $117.88B |
| P/E ratio | 36.9 | 33.0 |
| ROE | 13.38% | 16.02% |
| Profit margin | 14.94% | 13.78% |
| Revenue growth | 9.10% | 7.60% |
| Dividend yield | 0.27% | 1.14% |
| Beta | 0.84 | 0.77 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
TMO vs SYK in plain English
- TMO is the bigger company — about 2.2× the market cap of SYK.
- SYK is cheaper on earnings (P/E 33.0 vs 36.9).
- SYK earns a higher return on equity (16% vs 13%).
- TMO is growing revenue faster (9% vs 8%).
- SYK has the higher dividend yield (1.14% vs 0.27%).
How would $1,000 have done in each?
TMO return calculator
See what $1,000 in Thermo Fisher Scientific Inc. would be worth today.
SYK return calculator
See what $1,000 in Stryker Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.